Efficacy, Safety, and Survival Factors for Sorafenib Treatment in Japanese Patients with Advanced Hepatocellular Carcinoma
Masahito Nakano(Kurume University), Hajime Aino, Masahiko Kajiwara, Hironori Koga(Kurume University), Takuji Torimura(Omuta hospital), Shingo Yamada(Jichi Medical University), Norito Matsukuma(Yokkaichi Social Insurance Hospital), Junichi Kurogi(Kurume University), Hiroaki Nagamatsu, Manabu Satani(Kurume University), Masatoshi Tanaka(Fukushima Medical University), Akio Takata(Kurume University), Yoichi Yano, Kenji Sakata(Kanazawa University), Hideki Iwamoto, Kunitaka Fukuizumi(National Kyushu Medical Center), Ryoko Kuromatsu(Kurume University), Takashi Niizeki(Kurume University), Terufumi Sakai(St Mary's Hospital), Nobuyoshi Tajiri(Kurume University), Noriyuki Ono, Shuji Sumie(Kurume University), Satoru Matsugaki(Kurume University), Michio Sata(Kurume University)
Cited by 34
Related Papers
Therapeutic effects of restricted diet and exercise in obese patients with fatty liver
|Journal of Hepatology|1997|614
Clinical practice guidelines for hepatocellular carcinoma: The Japan Society of Hepatology 2017 (4th JSH‐HCC guidelines) 2019 update
|Hepatology Research|2019|539
Hepatitis C Virus Down-Regulates Insulin Receptor Substrates 1 and 2 through Up-Regulation of Suppressor of Cytokine Signaling 3
|American Journal Of Pathology|2004|536
Aerobic vs. resistance exercise in non-alcoholic fatty liver disease: A systematic review
|Journal of Hepatology|2016|504